- Home
- RLMD vs DRIO Comparison
RLMD vs DRIO Comparison
Compare RLMD & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- DRIO
- Stock Information
- Founded
- RLMD 2004
- DRIO 2011
- Country
- RLMD United States
- DRIO United States
- Employees
- RLMD N/A
- DRIO N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- RLMD Health Care
- DRIO Health Care
- Exchange
- RLMD Nasdaq
- DRIO Nasdaq
- Market Cap
- RLMD 20.3M
- DRIO 19.8M
- IPO Year
- RLMD N/A
- DRIO N/A
- Fundamental
- Price
- RLMD $0.63
- DRIO $0.57
- Analyst Decision
- RLMD Buy
- DRIO Strong Buy
- Analyst Count
- RLMD 3
- DRIO 2
- Target Price
- RLMD $5.00
- DRIO $2.50
- AVG Volume (30 Days)
- RLMD 142.9K
- DRIO 232.3K
- Earning Date
- RLMD 08-07-2025
- DRIO 08-12-2025
- Dividend Yield
- RLMD N/A
- DRIO N/A
- EPS Growth
- RLMD N/A
- DRIO N/A
- EPS
- RLMD N/A
- DRIO N/A
- Revenue
- RLMD N/A
- DRIO $27,148,000.00
- Revenue This Year
- RLMD N/A
- DRIO $0.74
- Revenue Next Year
- RLMD N/A
- DRIO $19.61
- P/E Ratio
- RLMD N/A
- DRIO N/A
- Revenue Growth
- RLMD N/A
- DRIO 41.79
- 52 Week Low
- RLMD $0.24
- DRIO $0.38
- 52 Week High
- RLMD $3.98
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- RLMD 51.70
- DRIO 53.97
- Support Level
- RLMD $0.59
- DRIO $0.42
- Resistance Level
- RLMD $0.64
- DRIO $0.47
- Average True Range (ATR)
- RLMD 0.05
- DRIO 0.05
- MACD
- RLMD 0.00
- DRIO 0.01
- Stochastic Oscillator
- RLMD 55.00
- DRIO 87.16
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.